by | | Newsroom
Clinical trials for clinical approval of the WoundViewer technology have ended. To find out more click on the link: https://pubmed.ncbi.nlm.nih.gov/33320742
by | | WeWin
Omnidermal Biomedics is strongly grateful to announce the award of the Emilia Romagna funding call to support research and innovation projects for the development of solutions aimed at contrasting of the COVID-19 epidemic. This grant was created to promote open...
by | | Newsroom
Omnidermal Biomedics is strongly grateful to announce the award of the Emilia Romagna funding call to support research and innovation projects for the development of solutions aimed at contrasting of the COVID-19 epidemic. This grant was created to promote open...
Recent Comments